CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research
Hun-Sung Kim, Hyunah Kim, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Sun Jung Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Kun-Ho Yoon
Endocrinol Metab. 2017;32(1):90-98.   Published online February 28, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.90

Excel Download

Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research
Endocrinology and Metabolism. 2017;32(1):90   Crossref logo
Link1 Link2 Link3

Newer HMG-CoA reductase inhibitor (statin) therapies
Clinical Cardiology. 2001;24(S2):10-13   Crossref logo
Link1 Link2

P-7-29 Long term effect of the HMG CoA reductase inhibitor (CS-514) on lipid and glucose metabolism of hyperlipidemic diabetics
Diabetes Research and Clinical Practice. 1987;3:S76   Crossref logo
Link1 Link2

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data
Atherosclerosis. 1998;138(1):11-24   Crossref logo
Link1 Link2

The pharmacology of fluvastatin, a new HMG-CoA reductase inhibitor
Clinical Cardiology. 2009;17(S4):IV-3-IV-10   Crossref logo
Link1 Link2

Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase
European Journal of Clinical Pharmacology. 1991;40(1):S15-S18   Crossref logo
Link1 Link2 Link3

Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase
European Journal of Clinical Pharmacology. 1991;40(S1):S15-S18   Crossref logo
Link1 Link2 Link3

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy
Clinical Endocrinology. 2007;68(2):326-326   Crossref logo
Link1 Link2

C4. Cost-effectiveness trends of HMG-CoA reductase inhibitor therapy in a managed-care population
Clinical Therapeutics. 1996;18:20-21   Crossref logo
Link1 Link2

HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions
Internal Medicine Journal. 2002;32(9-10):486-490   Crossref logo
Link1 Link2 Link3